Platinum Compounds: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

24 March 2024

  • curprev 05:1005:10, 24 March 2024‎ Lazy talk contribs‎ 489 bytes +489‎ Created page with "{{TreatmentInfo |drug_name=Platinum Compounds (Cisplatin) |FDA_approval=Yes |used_for=Glioblastoma |clinical_trial_phase=Various, including Phase II |common_side_effects=Nephrotoxicity, ototoxicity, and neurotoxicity |OS_with=Not specified |usefulness_rating=3 |notes=Combining Temodar with cisplatin has shown improved PFS-6 in recurrent tumors. A protocol combining Temodar, cisplatin, and etoposide reported median survival of 25 months. |category=Other Chemotherapy and C..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Platinum_Compounds"